Fintepla Interactions
There are 498 drugs known to interact with Fintepla (fenfluramine), along with 10 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 86 are major, 407 are moderate, and 5 are minor.
- View all 498 medications that may interact with Fintepla
- View Fintepla alcohol/food interactions (2)
- View Fintepla disease interactions (10)
Most frequently checked interactions
View interaction reports for Fintepla (fenfluramine) and the medicines listed below.
- Afinitor Disperz (everolimus)
- albuterol
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- clobazam
- clonazepam
- clonidine
- Copaxone (glatiramer)
- Cymbalta (duloxetine)
- Diacomit (stiripentol)
- Dibenzyline (phenoxybenzamine)
- Dyanavel XR (amphetamine)
- Eloctate (antihemophilic factor)
- Epidiolex (cannabidiol)
- Exforge HCT (amlodipine / hydrochlorothiazide / valsartan)
- Jynarque (tolvaptan)
- Kuvan (sapropterin)
- Lasix (furosemide)
- Luxturna (voretigene neparvovec ophthalmic)
- methotrexate
- midazolam
- MS Contin (morphine)
- Ocrevus (ocrelizumab)
- Oncovin (vincristine)
- Onfi (clobazam)
- Onpattro (patisiran)
- phenylephrine
- Phospholine Iodide (echothiophate iodide ophthalmic)
- Plegridy (peginterferon beta-1a)
- Savella (milnacipran)
Fintepla alcohol/food interactions
There are 2 alcohol/food interactions with Fintepla (fenfluramine).
Fintepla disease interactions
There are 10 disease interactions with Fintepla (fenfluramine) which include:
- psychiatric disorders
- cardiac disease
- pulmonary disease
- suicidal tendency
- alcoholism
- anorexia
- hypertension
- liver impairment
- renal dysfunction
- visual disturbance
More about Fintepla (fenfluramine)
- Fintepla consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CNS stimulants
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.